Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells.
Gall CLM, Fennemann FL, Van Der Schoot JMS, Scheeren FA, Verdoes M. Gall CLM, et al. Among authors: van der schoot jms. Bio Protoc. 2023 Feb 20;13(4):e4613. doi: 10.21769/BioProtoc.4613. eCollection 2023 Feb 20. Bio Protoc. 2023. PMID: 36845533 Free PMC article.
Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering.
van der Schoot JMS, Fennemann FL, Valente M, Dolen Y, Hagemans IM, Becker AMD, Le Gall CM, van Dalen D, Cevirgel A, van Bruggen JAC, Engelfriet M, Caval T, Bentlage AEH, Fransen MF, Nederend M, Leusen JHW, Heck AJR, Vidarsson G, Figdor CG, Verdoes M, Scheeren FA. van der Schoot JMS, et al. Sci Adv. 2019 Aug 28;5(8):eaaw1822. doi: 10.1126/sciadv.aaw1822. eCollection 2019 Aug. Sci Adv. 2019. PMID: 31489367 Free PMC article.
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Le Gall CM, van der Schoot JMS, Ramos-Tomillero I, Khalily MP, van Dalen FJ, Wijfjes Z, Smeding L, van Dalen D, Cammarata A, Bonger KM, Figdor CG, Scheeren FA, Verdoes M. Le Gall CM, et al. Among authors: van der schoot jms. Bioconjug Chem. 2021 Feb 17;32(2):301-310. doi: 10.1021/acs.bioconjchem.0c00673. Epub 2021 Jan 21. Bioconjug Chem. 2021. PMID: 33476135 Free PMC article.
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
van Elsas MJ, van der Schoot JMS, Bartels A, Steuten K, van Dalen D, Wijfjes Z, Figdor CG, van Hall T, van der Burg SH, Verdoes M, Scheeren FA. van Elsas MJ, et al. Among authors: van der schoot jms. Int J Mol Sci. 2022 Aug 5;23(15):8707. doi: 10.3390/ijms23158707. Int J Mol Sci. 2022. PMID: 35955841 Free PMC article.
Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents.
Hagemans IM, Wierstra PJ, Steuten K, Molkenboer-Kuenen JDM, van Dalen D, Ter Beest M, van der Schoot JMS, Ilina O, Gotthardt M, Figdor CG, Scheeren FA, Heskamp S, Verdoes M. Hagemans IM, et al. Among authors: van der schoot jms. J Nanobiotechnology. 2022 Feb 2;20(1):64. doi: 10.1186/s12951-022-01272-5. J Nanobiotechnology. 2022. PMID: 35109860 Free PMC article.
Correction to: Multiscale imaging of therapeutic anti-PD-L1 antibody localization using molecularly defined imaging agents Iris.
Hagemans IM, Wierstra PJ, Steuten K, Molkenboer-Kuenen JDM, van Dalen D, Ter Beest M, van der Schoot JMS, Ilina O, Gotthardt M, Figdor CG, Scheeren FA, Heskamp S, Verdoes M. Hagemans IM, et al. Among authors: van der schoot jms. J Nanobiotechnology. 2022 May 14;20(1):229. doi: 10.1186/s12951-022-01306-y. J Nanobiotechnology. 2022. PMID: 35568872 Free PMC article. No abstract available.